Article
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.
Antiviral therapy - 1 Jan 2006
Lapadula Giuseppe, Torti Carlo, Paraninfo Giuseppe, Castelnuovo Filippo, Uccelli Maria Cristina, Costarelli Silvia, Ladisa Nicoletta, Maserati Renato, Di Pietro Massimo, De Silvestri Annalisa, Tinelli Carmine, Puoti Massimo, Carosi Giampiero
Abstract excerpt
BACKGROUND: The independent role of HCV genotype 3 (HCV-3) in dyslipidaemia following highly active antiretroviral therapy (HAART) is still unexplored. METHODS: Analysis of data from a cohort of 307 HIV/HCV-coinfected patients and 415 HIV-monoinfected controls was conducted. Patients with available lipid levels at baseline and minimum 3-month follow-up were ranked into three groups by HCV status (HCV-3, other HCV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.